The cumulative incidence of death from breast cancer among breast cancer patients increased with increasing levels of CRP (Figure 2C; log-rank trend, P < 0.001) reaching 11%, 19%, and 20% among women in the lowest, middle, and highest tertile of CRP at the end of follow-up. Here, CRP is linked to breast carcinoma.